HealthcareCEO's reign saw turnover upEbos GroupTurnover at medical consumable and pharmaceutical products company Ebos Group has grown from around $8 million to $6 billion in the 27 years since Mark Waller became CEO.11 Dec 04:00 PM
HealthcareHelen Twose: Ebos chief's long road to growthWhen Mark Waller took over the top job at listed healthcare supplier Ebos, he never imagined he'd be dropping the reins 27 years later.30 Oct 04:00 PM
Aged careNZX's worst shares of 2014 (+graphic)What are the top 10 worst performing shares of 2014 so far? Find out with a graphic showing the biggest losers.28 Oct 11:00 PM
OpinionBrian GaynorBrian Gaynor: Companies must lift earnings performanceThe NZX will run out of steam unless companies, particularly the larger ones, can take advantage of the stronger economy, writes Brian Gaynor.28 Feb 04:30 PM
HealthcareStock Takes: Research shortfallEbos Group's $1.1 billion acquisition of Australian firm Symbion this week again highlighted an ongoing issue with getting independent research on NZX-listed companies.30 May 05:30 PM
OpinionBrian GaynorBrian Gaynor: Changing the scores unfair to investorsNormalising profits to bury the bottom line shouldn't be the norm.02 Sep 05:30 PM
ConstructionTelecom and Ebos up as NZ shares buck the trendThe New Zealand sharemarket rose yesterday when many other markets were weak and a large volume was traded in the shares of New Zealand Oil & Gas, the 29 per cent shareholder of Pike River Coal Ltd.24 Nov 04:30 PM
